Conference abstract · 22 Jun 2021
Conference abstractPublished 30 Jun 2016
Amorphous solid dispersions: Utilization and challenges in drug discovery and development
Sanofi Aventis Group, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Amorphous solid dispersion (ASD) can accelerate a project by improving dissolution rate and solubility, offering dose escalation flexibility and excipient acceptance for toxicology studies, as well as providing adequate preclinical and clinical exposure. The prerequisite physicochemical properties for a compound to form a stable ASD are glass forming ability and low crystallization tendency, which can be assessed using computational tools and experimental methods. The experimental polymer excipient screening techniques are discussed. Improved technologies for polymer screening with minimal quantity of drug substance, and the scalability of ASD from bench to commercial are reviewed. Considerations of in vitro evaluations, preclinical animal selection, and the translation of the preclinical results to clinical studies are also discussed. Better understanding of how polymers improve the stability of the amorphous phase in the solid state and how ASD improves bioavailability have facilitated the applications of ASD ranging from discovery research to preclinical development and further to commercialization. With the understanding of how ASDs are currently used in the pharmaceutical industry and what challenges remain to be solved, ASD can be applied to solve drug formulation problems at given research and development stages.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 30 Apr 2021
Physical stability and drug crystallization kinetics in amorphous solid dispersion
Short communication · 2021
Physical stability and drug crystallization kinetics in amorphous solid dispersions
Conference abstract · 2021
Physical stability and drug crystallization in amorphous solid dispersion
Conference abstract · 28 Aug 2017
Physical stability and drug crystallization kinetics in amorphous solid dispersions
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Yan He”
